1. Home
  2. IDYA vs KFY Comparison

IDYA vs KFY Comparison

Compare IDYA & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$38.85

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo Korn Ferry

KFY

Korn Ferry

HOLD

Current Price

$76.56

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
KFY
Founded
2015
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.7B
IPO Year
2019
1998

Fundamental Metrics

Financial Performance
Metric
IDYA
KFY
Price
$38.85
$76.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
3
Target Price
$52.86
$73.00
AVG Volume (30 Days)
599.8K
410.2K
Earning Date
05-06-2026
06-17-2026
Dividend Yield
N/A
2.90%
EPS Growth
61.90
13.48
EPS
N/A
1.32
Revenue
$218,710,000.00
$1,819,519,000.00
Revenue This Year
N/A
$6.92
Revenue Next Year
$201.05
$3.25
P/E Ratio
N/A
$58.16
Revenue Growth
3024.43
12.20
52 Week Low
$25.36
$58.27
52 Week High
$42.68
$87.51

Technical Indicators

Market Signals
Indicator
IDYA
KFY
Relative Strength Index (RSI) 52.15 33.61
Support Level $35.11 $66.62
Resistance Level $40.58 $79.97
Average True Range (ATR) 1.13 2.22
MACD -0.21 -0.83
Stochastic Oscillator 36.51 5.13

Price Performance

Historical Comparison
IDYA
KFY

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About KFY Korn Ferry

Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

Share on Social Networks: